Indivior (LON:INDV) Shares Down 20.6% – Here’s Why

Shares of Indivior PLC (LON:INDV) traded down 20.6% during mid-day trading on Thursday . The company traded as low as GBX 548.71 ($6.93) and last traded at GBX 689.44 ($8.71). 2,685,740 shares changed hands during trading, an increase of 267% from the average session volume of 731,626 shares. The stock had previously closed at GBX 868 ($10.97).

Analyst Upgrades and Downgrades

Separately, Jefferies Financial Group reiterated a “buy” rating and set a GBX 1,800 ($22.74) price target on shares of Indivior in a research report on Tuesday, December 17th.

Indivior Stock Performance

The company has a debt-to-equity ratio of -170.06, a quick ratio of 1.52 and a current ratio of 0.83. The company has a market capitalization of £1.08 billion, a price-to-earnings ratio of -570.87, a P/E/G ratio of -5.57 and a beta of 0.19. The stock’s 50-day moving average price is GBX 920.11 and its 200-day moving average price is GBX 850.81.

Indivior Company Profile

Indivior PLC, together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and co-occurring disorders in the United States, the United Kingdom, and internationally. The company develops medicines to treat substance use disorders, serious mental illnesses, and opioid overdose.